ArticlePloS one2026
Pyrococcus furiosus Argonaute coupled PCR assay for accurate discrimination between the MS-H vaccine strain and clinical isolates of Mycoplasma synoviae.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycoplasma synoviae (MS) is a significant avian pathogen responsible for arthritis, tenosynovitis, airsacculitis, and abnormal eggshell apex syndrome in chickens, posing a substantial threat to the poultry industry. While the attenuated MS-H vaccine has proven effective and is widely implemented in poultry flocks. However, distinguishing the MS-H vaccine strain from wild-type strains remains a persistent challenge. Recently, Pyrococcus furiosus Argonaute (PfAgo) nucleases have garnered considerable attention due to their capacity for single-nucleotide discrimination. Leveraging the A367G SNP within the MS obg gene, we developed a novel identification method that integrates PfAgo-mediated cleavage with PCR amplification. Through systematic optimization of PfAgo cleavage substrates and PCR primers, this approach achieved detection sensitivities of 1 × 103 copies/µL for the MS-H vaccine strain and 1 × 104 copies/µL for wild-type strains. Validation using 12 clinical samples resulted in the accurate identification of three MS-H vaccine strains and nine wild-type strains. The established method thus provides a reliable and sensitive tool for discriminating between MS-H vaccine and wild-type strains, supporting improved surveillance and control in poultry farming.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.